Baidu
map

Neurology:癫痫发作独立预测卒中静脉溶栓患者远期预后

2013-02-28 高晓方 译 医学论坛网

  瑞士学者的一项研究表明,静脉溶栓后3年约有1/3的患者具有良好转归;有1/3的患者死亡。癫痫性发作则对远期转归具有负面影响。论文于2013年2月13日在线发表于《神经病学》(Neurology)。   此项观察性研究共纳入257例接受静脉溶栓治疗的卒中患者。利用结构性电话访谈确定远期转归信息。主要转归指标为死亡和良好转归(改良Rankin量表评分为0和1)。计算Kaplan-Meier评估生

  瑞士学者的一项研究表明,静脉溶栓后3年约有1/3的患者具有良好转归;有1/3的患者死亡。癫痫性发作则对远期转归具有负面影响。论文于2013年2月13日在线发表于《神经病学》(Neurology)。

  此项观察性研究共纳入257例接受静脉溶栓治疗的卒中患者。利用结构性电话访谈确定远期转归信息。主要转归指标为死亡和良好转归(改良Rankin量表评分为0和1)。计算Kaplan-Meier评估生存率。通过单变量和多变量Logistic回归分析确认决定远期转归的独立变量。

  结果显示,患者中位随访时间为3.0年。静脉溶栓1、3和4年后的生存机率分别为76%、66%和53%。中位3年后37%的患者伴有良好转归。不良远期转归的独立预测因素为高龄(比值比[OR] 1.030;P=0.036)、3个月不良转归(OR 6.676;P<0.001)和癫痫发作出现(OR 4.899;P=0.016)。颅内出血、共病、性别、初始血糖或C反应蛋白水平以及卒中病因对远期转归无独立影响。

癫痫相关的拓展阅读:


Long-term outcome in stroke patients treated with IV thrombolysis

Objectives: Data on long-term outcome after IV thrombolysis (IVT) are sparse. Our goals were to 1) estimate annual survival, and 2) evaluate determinants for an unfavorable long-term outcome after IVT for stroke.

Methods: This observational study is based on the IVT registry of the University Hospital Basel. A structured telephone interview was used to ascertain information about long-term outcome (1 year to 10 years after IVT). Primary outcome parameters were 1) death and 2) excellent outcome (modified Rankin Scale scores 0 and 1). Kaplan-Meier survival estimates were calculated. Uni- and multivariate logistic regression analyses were performed to identify variables independently determining long-term outcome.

Results: Two hundred fifty-seven IVT-treated stroke patients were eligible for analysis. Median time of follow-up was 3.0 years (interquartile range 1.0–5.0). Probability of surviving after IVT was 76% after 1 year, 66% after 3 years, and 53% after 4 years. After a median of 3 years, 37% of patients had an excellent outcome. Independent predictors for unfavorable long-term outcome were advanced age (odds ratio [OR] 1.030, 95% confidence interval [CI] 1.002–1.060, p = 0.036), higher stroke severity (OR 1.100, 95% CI 1.012–1.196, p = 0.026), unfavorable 3-month outcome (OR 6.767, 95% CI 3.391–13.503, p < 0.001), and occurrence of epileptic seizures (OR 4.899, 95% CI 1.349–17.793, p = 0.016). Intracranial hemorrhage, comorbidity, sex, initial glucose or C-reactive protein levels, and stroke etiology did not independently influence long-term outcome.

Conclusion: At 3 years after IVT, approximately 1 of 3 stroke patients had an excellent outcome, and 1 of 3 had died. Epileptic seizures seem to have an unfavorable effect on long-term outcome via a mechanism that remains to be clarified.


    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1999266, encodeId=623a1999266fc, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Aug 02 21:11:00 CST 2013, time=2013-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984368, encodeId=58b019843689a, content=<a href='/topic/show?id=c4bb9443038' target=_blank style='color:#2F92EE;'>#远期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94430, encryptionId=c4bb9443038, topicName=远期预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c2e485, createdName=yangfl06, createdTime=Sat Apr 20 22:11:00 CST 2013, time=2013-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697155, encodeId=22b4169e155f7, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sun Jul 28 13:11:00 CST 2013, time=2013-07-28, status=1, ipAttribution=)]
    2013-08-02 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=1999266, encodeId=623a1999266fc, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Aug 02 21:11:00 CST 2013, time=2013-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984368, encodeId=58b019843689a, content=<a href='/topic/show?id=c4bb9443038' target=_blank style='color:#2F92EE;'>#远期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94430, encryptionId=c4bb9443038, topicName=远期预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c2e485, createdName=yangfl06, createdTime=Sat Apr 20 22:11:00 CST 2013, time=2013-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697155, encodeId=22b4169e155f7, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sun Jul 28 13:11:00 CST 2013, time=2013-07-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1999266, encodeId=623a1999266fc, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Aug 02 21:11:00 CST 2013, time=2013-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984368, encodeId=58b019843689a, content=<a href='/topic/show?id=c4bb9443038' target=_blank style='color:#2F92EE;'>#远期预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94430, encryptionId=c4bb9443038, topicName=远期预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c2e485, createdName=yangfl06, createdTime=Sat Apr 20 22:11:00 CST 2013, time=2013-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1697155, encodeId=22b4169e155f7, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Sun Jul 28 13:11:00 CST 2013, time=2013-07-28, status=1, ipAttribution=)]
    2013-07-28 fusion

相关资讯

FDA:警惕MS药物的癫痫发作风险

美国食品药品管理局(FDA)对多发性硬化症(MS)药物达伐吡啶(dalfampridine)上市后不良事件报告的评估结果表明,患者开始接受推荐剂量的达伐吡啶治疗后不久,癫痫发作风险即达到最高程度。 7月23日FDA发布声明指出,癫痫发作是该药物的已知风险,大部分患者的癫痫发作出现在开始治疗后数天至数周内,无任何癫痫史的患者也可能发生。癫痫发作风险随血药浓度增加而增加。鉴于该药物通过肾脏消除,因此

Baidu
map
Baidu
map
Baidu
map